These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8663420)

  • 1. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts.
    Kurokawa M; Tanaka T; Tanaka K; Hirano N; Ogawa S; Mitani K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Jul; 271(28):16870-6. PubMed ID: 8663420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
    Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1.
    Tanaka K; Tanaka T; Kurokawa M; Imai Y; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Blood; 1998 Mar; 91(5):1688-99. PubMed ID: 9473235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution properties of the free and DNA-bound Runt domain of AML1.
    Wolf-Watz M; Xie XQ; Holm M; Grundström T; Härd T
    Eur J Biochem; 1999 Apr; 261(1):251-60. PubMed ID: 10103057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
    Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
    Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues.
    Akamatsu Y; Ohno T; Hirota K; Kagoshima H; Yodoi J; Shigesada K
    J Biol Chem; 1997 Jun; 272(23):14497-500. PubMed ID: 9169404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C; Rowley JD; Nucifora G
    Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
    Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
    Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias.
    Mao S; Frank RC; Zhang J; Miyazaki Y; Nimer SD
    Mol Cell Biol; 1999 May; 19(5):3635-44. PubMed ID: 10207087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
    Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
    J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome.
    Imai O; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
    Leuk Lymphoma; 2002 Mar; 43(3):617-21. PubMed ID: 12002768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
    Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
    Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.
    Bae SC; Ogawa E; Maruyama M; Oka H; Satake M; Shigesada K; Jenkins NA; Gilbert DJ; Copeland NG; Ito Y
    Mol Cell Biol; 1994 May; 14(5):3242-52. PubMed ID: 8164679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AML1/ETO fusion protein activates transcription of BCL-2.
    Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
    Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
    Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis.
    Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Takeuchi K; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
    Blood; 2000 Nov; 96(9):3154-60. PubMed ID: 11049997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta.
    Warren AJ; Bravo J; Williams RL; Rabbitts TH
    EMBO J; 2000 Jun; 19(12):3004-15. PubMed ID: 10856244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia.
    Miyoshi H; Ohira M; Shimizu K; Mitani K; Hirai H; Imai T; Yokoyama K; Soeda E; Ohki M
    Nucleic Acids Res; 1995 Jul; 23(14):2762-9. PubMed ID: 7651838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.
    Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.